Nasim Musa is serving as Medical Director and Chief Consultant, NIPRO JMI Dialysis Center Limited, Bangladesh. He is board certified in MBBS at Dhaka university, and M. MED Science in Nephrology at university of Sheffield, UK.


Patients with Insulin Dependent Diabetes Mellitus (IDDM) patients posses high risk of developing diabetic nephropathy. The goals of treatment of diabetic nephropathy are to slow the progression of kidney damage and control related complications. Studies have shown that Angiotensin Converting Enzymes Inhibitor (ACEI) and Angiotensin Receptor Blockers (ARB) are beneficial in reducing the progression of microalbuminuria in normotensive patients with type 1 diabetes. Current effort to perform a systematic review of available published evidence regarding role of ACEI and ARB in type I diabetic nephropathy and to assess whether these drugs are helpful in improving renal function, slowing progression of chronic renal failure in patients IDDM with nephropathy.

Speaker Presentations

Speaker PDFs

Speaker PPTs

Download PPT